Annual Total Long Term Liabilities
$3.24 M
-$660.00 K-16.94%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual total long term liabilities is $3.24 million, with the most recent change of -$660.00 thousand (-16.94%) on December 31, 2023.
- During the last 3 years, MTNB annual total long term liabilities has fallen by -$433.00 thousand (-11.80%).
- MTNB annual total long term liabilities is now -27.83% below its all-time high of $4.48 million, reached on December 31, 2021.
Performance
MTNB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.67 M
-$196.00 K-6.83%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly total long term liabilities is $2.67 million, with the most recent change of -$196.00 thousand (-6.83%) on September 30, 2024.
- Over the past year, MTNB quarterly long term liabilities has dropped by -$738.00 thousand (-21.63%).
- MTNB quarterly long term liabilities is now -42.27% below its all-time high of $4.63 million, reached on September 30, 2021.
Performance
MTNB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MTNB Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.9% | -21.6% |
3 y3 years | -11.8% | -21.6% |
5 y5 years | +236.5% | -21.6% |
MTNB Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.8% | at low | -40.4% | at low |
5 y | 5-year | -27.8% | at low | -42.3% | at low |
alltime | all time | -27.8% | -100.0% | -42.3% | -100.0% |
Matinas BioPharma Holdings Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.67 M(-6.8%) |
Jun 2024 | - | $2.87 M(-6.0%) |
Mar 2024 | - | $3.05 M(-5.6%) |
Dec 2023 | $3.24 M(-16.9%) | $3.24 M(-5.2%) |
Sep 2023 | - | $3.41 M(-4.7%) |
Jun 2023 | - | $3.58 M(-4.3%) |
Mar 2023 | - | $3.74 M(-4.0%) |
Dec 2022 | $3.90 M(-13.1%) | $3.90 M(-3.2%) |
Sep 2022 | - | $4.03 M(-3.8%) |
Jun 2022 | - | $4.18 M(-3.5%) |
Mar 2022 | - | $4.33 M(-3.3%) |
Dec 2021 | $4.48 M(+22.2%) | $4.48 M(-3.2%) |
Sep 2021 | - | $4.63 M(+33.2%) |
Jun 2021 | - | $3.48 M(-2.7%) |
Mar 2021 | - | $3.57 M(-2.6%) |
Dec 2020 | $3.67 M(-10.3%) | $3.67 M(-2.5%) |
Sep 2020 | - | $3.76 M(-2.4%) |
Jun 2020 | - | $3.85 M(-2.8%) |
Mar 2020 | - | $3.97 M(-3.0%) |
Dec 2019 | $4.09 M | $4.09 M(-2.9%) |
Sep 2019 | - | $4.21 M(-2.8%) |
Jun 2019 | - | $4.33 M(-2.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $4.45 M(+362.8%) |
Dec 2018 | $961.60 K(-51.3%) | $961.60 K(-34.7%) |
Sep 2018 | - | $1.47 M(-27.4%) |
Jun 2018 | - | $2.03 M(+0.1%) |
Mar 2018 | - | $2.03 M(+2.7%) |
Dec 2017 | $1.97 M(+61.5%) | $1.97 M(+6.3%) |
Sep 2017 | - | $1.86 M(+47.7%) |
Jun 2017 | - | $1.26 M(+3.1%) |
Mar 2017 | - | $1.22 M(-0.2%) |
Dec 2016 | $1.22 M(+1.4%) | $1.22 M(-0.2%) |
Sep 2016 | - | $1.22 M(-0.1%) |
Jun 2016 | - | $1.23 M(+1.7%) |
Mar 2016 | - | $1.21 M(0.0%) |
Dec 2015 | $1.21 M(+7776.5%) | $1.21 M(-40.8%) |
Sep 2015 | - | $2.04 M(-3.0%) |
Jun 2015 | - | $2.10 M(0.0%) |
Mar 2015 | - | $2.10 M(>+9900.0%) |
Dec 2014 | $15.30 K(>+9900.0%) | $15.30 K(-32.0%) |
Sep 2014 | - | $22.50 K(-33.0%) |
Jun 2014 | - | $33.60 K(-22.9%) |
Mar 2014 | - | $43.60 K(>+9900.0%) |
Dec 2013 | $0.00 | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual total long term liabilities?
- What is the all time high annual total long term liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual total long term liabilities year-on-year change?
- What is Matinas BioPharma Holdings quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly long term liabilities year-on-year change?
What is Matinas BioPharma Holdings annual total long term liabilities?
The current annual total long term liabilities of MTNB is $3.24 M
What is the all time high annual total long term liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total long term liabilities is $4.48 M
What is Matinas BioPharma Holdings annual total long term liabilities year-on-year change?
Over the past year, MTNB annual total long term liabilities has changed by -$660.00 K (-16.94%)
What is Matinas BioPharma Holdings quarterly total long term liabilities?
The current quarterly long term liabilities of MTNB is $2.67 M
What is the all time high quarterly long term liabilities for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total long term liabilities is $4.63 M
What is Matinas BioPharma Holdings quarterly long term liabilities year-on-year change?
Over the past year, MTNB quarterly total long term liabilities has changed by -$738.00 K (-21.63%)